Amgen Invited for ODAC Meeting to Discuss XGEVA sBLA
Amgen plans to discuss the proposed sBLA with ODAC, to support the use of XGEVA in the treatment of men with non-metastatic CRPC.
The U.S. FDA has invited Amgen to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
The ODAC will review results from clinical studies in support of this new indication, including the pivotal '147 trial, a randomized, placebo-controlled, multi-center Phase 3 study that compared XGEVA to placebo in prolonging bone metastasis-free survival in men with non-metastatic CRPC who were at high risk for bone metastases based on prostate specific antigen criteria.
Amgen plans to discuss the proposed sBLA with ODAC, to support the use of XGEVA in the tre
Related News
-
News CPHI Americas 2026 - From the Floor
Our From the Floor live blog returns to Philadelphia for CPHI Americas 2026, continuing to showcase the entire pharmaceutical supply chain from north to south across the Americas.
-
News DCAT Week 2026: Insights from Thermo Fisher Scientific
Anil Kane, PhD, MBA, serves as the Executive Director and Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, a global leader in scientific research and innovation. In this exclusive interview, Kane shares his and Thermo Fisher&#... -
News A Day in the Life of a CPHI Attendee
The series aims to highlight some of the indispensable talent involved in all aspects of the pharma value chain, getting to know the people working towards better healthcare across the world. This special edition aims to get to know the people attendin... -
News CPHI Pharma Awards 2026: Recognising Excellence in an Evolving Industry
Submissions now open — deadline May 16
-
News Packaging Under Pressure: Where Sustainability in Pharma Meets Reality
A Reflection on the Sustainability Collective Roundtable Session at Pharmapack 2026
-
News Where Pharma Innovation Takes the Spotlight: Pharmapack Awards 2026
The 2026 Pharmapack Awards, held January 21, 2026, celebrated and recognised leading companies in the pharmaceutical packaging sector paving the way for packaging and drug delivery excellence in the future.
-
News Pharmapack 2026 - From the Floor
Celebrating its 25th anniversary in the city where it all started, Pharmapack 2026 is back in Paris! From January 21-22, 2026, Paris Expo Porte de Versailles opens its doors again to the pharmaceutical packaging and drug delivery sectors, ready for 2 d... -
News Reshaping Pharmaceutical Packaging’s Sustainable Future at Pharmapack 2026
Pharmapack 2026 returns as the pharmaceutical packaging industry's premier gathering, bringing together global leaders, innovators, and decision-makers for an unparalleled showcase of cutting-edge solutions and strategic insights.